Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (221-230 of 596) with videos related to

Pageof 60
Sort By:
Leukemia|October 21, 2022
SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phaseSandra Huber, Torsten Haferlach, Manja Meggendorfer, et al.
Haematologica|July 6, 2019
"Somatic" and "pathogenic" - is the classification strategy applicable in times of large-scale sequencing?Constance Baer, Wencke Walter, Stephan Hutter, et al.
Leukemia Research|January 17, 2015
AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patientsTamara Alpermann, Claudia Haferlach, Christiane Eder, et al.
Haematologica|February 6, 2014
Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated casesAnnette Fasan, Claudia Haferlach, Alexander Kohlmann, et al.
Blood Cancer Journal|May 19, 2025
Two ways to complex karyotype in MDS-the role of del(5q) and TP53Sandra Huber, Stephan Hutter, Constance Baer, et al.
Molecular Biology Reports|September 28, 2022
Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutationSusanne Bracher, Irene Fuhrmann, Sabine Jeromin, et al.
Haematologica|April 23, 2016
Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemiaConstance Baer, Wolfgang Kern, Sarah Koch, et al.
Leukemia|October 19, 2022
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosisSandra Huber, Torsten Haferlach, Manja Meggendorfer, et al.
British Journal of Haematology|July 22, 2014
Quantification of rare NPM1 mutation subtypes by digital PCRUlrike Bacher, Frank Dicker, Claudia Haferlach, et al.
British Journal of Haematology|June 14, 2014
A robust molecular pattern for myelodysplastic syndromes in two independent cohorts investigated by next-generation sequencing can be revealed by comparative bioinformatic analysesDominic Rose, Alexander Kohlmann, Yasunobu Nagata, et al.
Pageof 60

Showing results (221-230 of 596) with videos related to

Sort By:
Pageof 60
Leukemia|October 21, 2022
SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phaseSandra Huber, Torsten Haferlach, Manja Meggendorfer, et al.
Haematologica|July 6, 2019
"Somatic" and "pathogenic" - is the classification strategy applicable in times of large-scale sequencing?Constance Baer, Wencke Walter, Stephan Hutter, et al.
Leukemia Research|January 17, 2015
AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patientsTamara Alpermann, Claudia Haferlach, Christiane Eder, et al.
Haematologica|February 6, 2014
Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated casesAnnette Fasan, Claudia Haferlach, Alexander Kohlmann, et al.
Blood Cancer Journal|May 19, 2025
Two ways to complex karyotype in MDS-the role of del(5q) and TP53Sandra Huber, Stephan Hutter, Constance Baer, et al.
Molecular Biology Reports|September 28, 2022
Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutationSusanne Bracher, Irene Fuhrmann, Sabine Jeromin, et al.
Haematologica|April 23, 2016
Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemiaConstance Baer, Wolfgang Kern, Sarah Koch, et al.
Leukemia|October 19, 2022
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosisSandra Huber, Torsten Haferlach, Manja Meggendorfer, et al.
British Journal of Haematology|July 22, 2014
Quantification of rare NPM1 mutation subtypes by digital PCRUlrike Bacher, Frank Dicker, Claudia Haferlach, et al.
British Journal of Haematology|June 14, 2014
A robust molecular pattern for myelodysplastic syndromes in two independent cohorts investigated by next-generation sequencing can be revealed by comparative bioinformatic analysesDominic Rose, Alexander Kohlmann, Yasunobu Nagata, et al.
Pageof 60